Stephanie R. Land
National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistics Center
University of Pittsburgh
Pittsburgh
PA 15213
USA
Name/email consistency: high
- Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. Land, S.R., Kopec, J.A., Julian, T.B., Brown, A.M., Anderson, S.J., Krag, D.N., Christian, N.J., Costantino, J.P., Wolmark, N., Ganz, P.A. J. Clin. Oncol. (2010)
- Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. Land, S.R., Kopec, J.A., Cecchini, R.S., Ganz, P.A., Wieand, H.S., Colangelo, L.H., Murphy, K., Kuebler, J.P., Seay, T.E., Needles, B.M., Bearden, J.D., Colman, L.K., Lanier, K.S., Pajon, E.R., Cella, D., Smith, R.E., O'Connell, M.J., Costantino, J.P., Wolmark, N. J. Clin. Oncol. (2007)
- Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches. Land, S.R., Ritter, M.W., Costantino, J.P., Julian, T.B., Cronin, W.M., Haile, S.R., Wolmark, N., Ganz, P.A. J. Clin. Oncol. (2007)
- Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. Land, S.R., Wickerham, D.L., Costantino, J.P., Ritter, M.W., Vogel, V.G., Lee, M., Pajon, E.R., Wade, J.L., Dakhil, S., Lockhart, J.B., Wolmark, N., Ganz, P.A. JAMA (2006)